| |
| |
SPOT ON
|
| |
Certified continuous medical education (CME): promotion rather than education
|
| |
| |
REVIEW
|
| |
Treatment of dyspepsia (part 1)
|
| |
| |
THERAPY FROM A CRITICAL VIEWPOINT
|
| |
Mumps despite vaccination
DETOX N for smoking cessation?
|
| |
| |
IN BRIEF
|
| |
Increased cancer risk due to ezetimib plus simvastatin (INEGY)?
Eradication of helicobacter: sequential or "conventional"
|
 |
HPV-vaccines in USA: CERVARIX still no approval, GARDASIL not for over 26 years old
Trastuzumab (HERCEPTIN) for adjuvant therapy of breast cancer: Roche comments a-t article
|
| |
| |
CURRENT ADR NETWORK REPORT
|
| |
Fatal interaction due to brivudin (ZOSTEX) and capecitabine (XELODA)
|
| |
| |
SIDE EFFECTS
|
| |
Gyrase inhibitor moxifloxacin (e.g. AVALOX): restricted to reserve status
|
| |